SoftBank founder Masayoshi Son speaks in futuristic terms about his company, but the success of his late-stage VC fund is still unknown.Technologyread more
Reports of Tesla vehicles spontaneously catching fire could make customers wary of EVs just as the industry ramps up production plans.Autosread more
Amazon's large and flashy investments stand out from those of its tech peers over the past year.Technologyread more
Huawei Technologies will immediately lose access to updates to the Android operating system, a source close the matter told Reuters.Technologyread more
Trump's relationships with Deutsche Bank have drawn scrutiny in Congress and elsewhere. Trump sued the bank last month to prevent it from complying with Congressional...Financeread more
The 2019 PGA Championship wraps up on Sunday, May 19. Here's how much money the champion will earn.Earnread more
Consumer IPOs from Snap to Uber have been disappointing and serve as a reminder that private investors are making all the money.Technologyread more
China's currency has been an important barometer for progress in U.S.-Chinese trade talks, and right now it's signaling things aren't going well.Market Insiderread more
The move comes after star runner Alysia Montaño's May 12 op-ed in the New York Times in which she detailed her experiences with Nike.Retailread more
The outrage has even inspired a Change.org petition called "Remake Game of Thrones Season 8 with competent writers," with over half-a-million signatories and climbing.Entertainmentread more
While the prolonged fight has been devastating to an already-struggling agriculture industry, there's little indication Trump is paying a political price.Traderead more
There are three things that are triggering the CVS-Aetna deal and one of them is Amazon, former Aetna CEO John Rowe told CNBC on Monday.
The deal would combine CVS' pharmacy business and pharmacy-benefit-manager platform (PBM) with Aetna's insurance business.
"Both of these companies are trying to increase their footprint in health care," Rowe said in an interview with "Closing Bell. "
The deal comes as ecommerce giant Amazon looks to enter the industry, holding preliminary talks with generic-drug makers.
"It's not quite explicit yet what they're planning on doing but whatever it is, it's scaring CVS," Rowe said about Amazon.
Another thing spurring the deal is United Healthcare, which "has had some success with their integrated model of a payer provider," he added.
Lastly, he thinks the failure of recent horizontal mergers, like Aetna-Humana deal, has forced companies to think more vertically across sectors to increase their footprint.
The CEOs of Aetna and CVS both told CNBC on Monday that the merger will reduce health-care costs for consumers immediately.
Rowe believes there are two areas that will see costs reduced — at the point of care at CVS Minute Clinics and in premiums.
"The infusion of millions of Aetna members into CVS program is going to give them more leverage with the drug wholesalers," he said.